Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder

BACKGROUND: Lorcaserin, a high-affinity 5-HT(2C) receptor agonist approved for treating obesity, decreased self-administration of oxycodone and cue-induced reinstatement of drug-seeking behavior in preclinical studies. The current investigation is the first clinical trial to evaluate the ability of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Alcohol Depend
Main Authors: Brandt, Laura, Jones, Jermaine D., Martinez, Suky, Manubay, Jeanne M., Mogali, Shanthi, Ramey, Tatiana, Levin, Frances R., Comer, Sandra D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7063580/
https://ncbi.nlm.nih.gov/pubmed/31980285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.107859
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados